Kikuchi Yuka Sugawara, Kanbayashi Takashi, Shimizu Tetsuo
Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita, Japan.
Psychiatry Investig. 2018 Apr;16(4):279-284. doi: 10.30773/pi.2018.12.16. Epub 2019 Apr 8.
The objective of this study was to investigate the relationship between the serum concentration of clozapine (C-CLZ), Ndesmethylclozapine (N-CLZ) and the daily dose of CLZ (D-CLZ), and the relationships among CLZ and electroencephalogram (EEG) abnormalities.
Twenty-eight patients were recruited to this study, but 8 patients were excluded because clozapine was discontinued before the post-treatment measurement of EEG or C-CLZ. Ultimately, 20 patients (6 men, 14 women) with an average age of 36 years were enrolled. The subjects were divided into EEG normal and abnormal groups. C-CLZ and N-CLZ were measured at 4, 12, 26, and 52 weeks after initiating CLZ administration.
All patients had normal baseline EEG signals, and 8 patients showed EEG abnormalities later. There were significant correlations between C-CLZ and D-CLZ, and between N-CLZ and D-CLZ. The C-CLZ/D-CLZ, N-CLZ/D-CLZ, and C-CLZ/N-CLZ ratio were not significantly different between the EEG normal and EEG abnormal groups. The EEG abnormal group had significant higher proportion of patients with high intra-individual variability in their C-CLZ/D-CLZ ratio.
There is no relationship between C-CLZ and EEG abnormalities. However, patients with high intra-individual variability in their C-CLZ/D-CLZ ratio had greater possibility of exhibiting EEG abnormalities.
本研究旨在探讨氯氮平血清浓度(C-CLZ)、去甲氯氮平(N-CLZ)与氯氮平日剂量(D-CLZ)之间的关系,以及氯氮平与脑电图(EEG)异常之间的关系。
招募了28名患者参与本研究,但有8名患者被排除,因为在治疗后脑电图或C-CLZ测量前停用了氯氮平。最终,纳入了20名患者(6名男性,14名女性),平均年龄36岁。将受试者分为脑电图正常组和异常组。在开始服用氯氮平后的4、12、26和52周测量C-CLZ和N-CLZ。
所有患者基线脑电图信号均正常,8名患者后来出现脑电图异常。C-CLZ与D-CLZ之间以及N-CLZ与D-CLZ之间存在显著相关性。脑电图正常组和异常组之间的C-CLZ/D-CLZ、N-CLZ/D-CLZ和C-CLZ/N-CLZ比值无显著差异。脑电图异常组中C-CLZ/D-CLZ比值个体内变异性高的患者比例显著更高。
C-CLZ与脑电图异常之间无关联。然而,C-CLZ/D-CLZ比值个体内变异性高的患者出现脑电图异常的可能性更大。